RhumbLine Advisers’s Intermolecular, Inc. IMI Stock Holding History

RhumbLine Advisers’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-14,147	Closed	-$40K	–	3100
2014 Q1	$40K	Sell	14,147 -850	-6%	-$3.1K	﹤0.01%	2966
2013 Q4	$74K	Hold	14,997	–	–	﹤0.01%	2982
2013 Q3	$83K	Sell	14,997 -161	-1%	-$1.01K	﹤0.01%	2949
2013 Q2	$110K	Buy	+15,158	New	+$129K	﹤0.01%	3219

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

RhumbLine Advisers's IMI Position: Q2 2014 in Review

RhumbLine Advisers sold out of Intermolecular, Inc. (IMI) in Q2 2014, closing a stake of 14,147 shares — an estimated $40K sold.

RhumbLine Advisers first reported a position in IMI in Q2 2013 and held it in 4 quarters. The position peaked at $110K in Q2 2013. 43 funds tracked by Wall St. Rank hold IMI as of Q2 2014.

RhumbLine Advisers reported no remaining Intermolecular, Inc. position as of Q2 2014 after selling out during the quarter.
RhumbLine Advisers sold 14,147 Intermolecular, Inc. shares in Q2 2014, an estimated $40K.
RhumbLine Advisers first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 4 quarters.
RhumbLine Advisers's Intermolecular, Inc. position peaked at $110K in Q2 2013.
43 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2014.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.